Bristol-Myers Squibb Company (NYSE:BMY) will host a teleconference on Tuesday, September 8 at 8 a.m. EDT (6 a.m. MDT) to review data presented at the 16th Annual World Conference on Lung Cancer (WCLC) in Denver, CO.
Â
Company executives will provide an overview of data presented on our Immuno-Oncology portfolio at the meeting, and address inquiries from investors and analysts.
Investors and the general public are invited to listen to a live webcast of the call at http://investor.bms.com, by dialing U.S. toll-free (877) 201-0168 or international (647) 788-4901, confirmation code: 29586971. Materials related to the call will be available at the same website prior to the call. A replay of the call will be available beginning at 10:30 p.m. EDT on September 8 through 11:59 p.m. EDT on September 23. The replay can be accessed at http://investor.bms.com or by dialing U.S. toll-free (855) 859-2056 or international (404) 537-3406, confirmation code: 29586971.
Â
